CEDAR RAPIDS, IA, August 29, 2005 - Embria (TM) Health Sciences announced today its entry into the human nutrition market. Embria is headquartered in Cedar Rapids, Iowa and was founded to manufacture science-backed natural ingredients for use in high-quality nutritional products.
Embria's initial offering, eXselen (TM), is a fully pasteurized selenium yeast that yields high levels of selenomethionine, an organic form of selenium that rapidly metabolizes within the body to yield high bioavailability and retention.
Embria's key products are manufactured using a proprietary technology, which produces vital metabolites that deliver nutritional benefits and support increased bioavailability. This premier technology is based on a similar process pioneered by Embria's parent company, Diamond V (R) Mills, Inc., a leader in animal nutrition ingredients and fermented yeast products since 1943, that has set the standard in the animal nutrition industry for more than 60 years.
Embria has appointed Paul R. Faganel to the position of company president. A Diamond V executive for more than 10 years, Faganel spearheaded the initial research efforts that validated that Diamond V's products have safe and beneficial applications for human health. As president, Faganel is responsible for all financial, legal and marketing functions, as well as spearheading strategic planning and business development efforts. He also oversees the ongoing scientific studies that support the safety, quality and efficacy of Embria's products and processes.
"Embria's business philosophy is based on the innovative application of new technologies to human nutrition," Faganel states. "We look forward to carving a science-driven niche within the ingredient supply market through our unique approach to human health and longevity."
# # #